药明合联(2268.HK)拉升大涨超13%，报79.1港元，股价创去年10月以来新高，截至目前成交额放大至11.6亿港元。消息面上，公司昨晚公布业绩显示，2026年上半年股东应占盈利8.19亿元，同比增长9.87%，每股盈利65分，不派息。期内，收益37.01亿元，同比增加37.04%。毛利率37%，上升0.9个百点。经调整盈利10.27亿元，按实际汇率计算同比增长37.4%。药明合联年内累涨29%。
药明合联(2268.HK)拉升大涨超13%，报79.1港元，股价创去年10月以来新高，截至目前成交额放大至11.6亿港元。消息面上，公司昨晚公布业绩显示，2026年上半年股东应占盈利8.19亿元，同比增长9.87%，每股盈利65分，不派息。期内，收益37.01亿元，同比增加37.04%。毛利率37%，上升0.9个百点。经调整盈利10.27亿元，按实际汇率计算同比增长37.4%。药明合联年内累涨29%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.